ctrl K

Watchlist Price Alert

Royalty Pharma (RPRX)

NASDAQ: RPRX · Real-Time Price · USD

32.62

-0.07 (-0.21%)

At close: May 28, 2025, 3:59 PM

32.63

0.03%

After-hours: May 28, 2025, 04:38 PM EDT

Royalty Pharma Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Financial Royalty Assets Revenue	2.15B	2.2B	2.13B	2.07B	1.96B
Financial Royalty Assets Revenue Growth	-2.20%	+3.42%	+2.91%	+5.36%	n/a
Royalty Income, Other Revenue	114.15M	155.97M	74.64M	53.13M	19M
Royalty Income, Other Revenue Growth	-26.81%	+108.97%	+40.47%	+179.70%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	110.7M	68M	56.72M	54.71M	57.65M	59M	57.23M	47.63M	85.69M	73.23M	50.69M	51.84M	51.54M	46.16M	48.59M	44.92M	43.16M	50M	51M	42.8M	38.06M	23.06M	25.6M	30.35M	24.43M
Selling, General, and Administrative Revenue Growth	+62.80%	+19.89%	+3.68%	-5.11%	-2.28%	+3.09%	+20.15%	-44.41%	+17.02%	+44.46%	-2.22%	+0.59%	+11.65%	-5.00%	+8.16%	+4.09%	-13.69%	-1.96%	+19.16%	+12.44%	+65.06%	-9.93%	-15.64%	+24.25%	n/a
Research and Development Revenue	50.5M	1M	500K	500K	500K	1M	50.5M	500K	500K	50.5M	25.5M	606K	100.5M	103.82M	90.5M	3.12M	2.64M	8M	5M	5.78M	7.64M	15.87M	22.72M	21.46M	22.99M
Research and Development Revenue Growth	+4950.00%	+100.00%	0.00%	0.00%	-50.00%	-98.02%	+10000.00%	0.00%	-99.01%	+98.04%	+4107.92%	-99.40%	-3.20%	+14.72%	+2798.78%	+18.21%	-66.99%	+60.00%	-13.43%	-24.39%	-51.87%	-30.14%	+5.88%	-6.67%	n/a